This Week in Hearing

Featured image for “Inside the Auracast Debut at the Sydney Opera House: A New Era in Hearing Accessibility”
Mar. 31, 2025

Inside the Auracast Debut at the Sydney Opera House: A New Era in Hearing Accessibility

HHTM
Auracast has officially launched at the world-renowned Sydney Opera House, setting a new standard for hearing accessibility in live events. In this special episode, Andrew Bellavia takes us behind the scenes of this groundbreaking event, where he explores the powerful capabilities of Auracast technology and its transformative impact on hearing accessibility. Andrew reflects on his personal experience with Auracast technology
Featured image for “Exploring Caption Companion: A Tool for Real-Time Captioning Without Internet”
Mar. 26, 2025

Exploring Caption Companion: A Tool for Real-Time Captioning Without Internet

HHTM
Caption Companion is a tool designed to provide real-time captioning without requiring an internet connection. In this conversation, Shari Eberts is joined by Margaret Downs, Executive Director of Premier Visual Voice, and Mathew Call, Director of Technology, to explore how this device can enhance accessibility for people with hearing loss. Equipped with a wireless microphone and user-friendly interface, Caption Companion
Featured image for “Exploring Widex Allure Hearing Aids: W1 Chip, Cloud Fitting, and Advanced Sound Control”
Mar. 19, 2025

Exploring Widex Allure Hearing Aids: W1 Chip, Cloud Fitting, and Advanced Sound Control

HHTM
Widex this week introduced Widex Allure, a new hearing aid platform designed to enhance speech clarity and improve awareness in various listening environments. Featuring the W1 chip and ‘Precision Hearing Technology’, the platform focuses on delivering clearer speech while maintaining natural sound awareness. In this conversation with Shari Eberts, Dana Helmink, Doctor of Audiology and Senior Director of Clinical Development
Featured image for “How Personalized Audio is Making Hearing Care More Accessible with Audeara CEO, James Fielding”
Mar. 17, 2025

How Personalized Audio is Making Hearing Care More Accessible with Audeara CEO, James Fielding

HHTM
How will personalized audio solutions shape the future of hearing health? Dr. James Fielding, CEO of Audeara, discusses how integrating personalized sound is transforming both hearing care and consumer audio. In this conversation, Fielding takes us through Audeara’s journey, from its early days of custom audio devices to its expansion into hearing aid solutions. Audeara’s innovative approach is reshaping the
Featured image for “The Brain’s Adaptive Mechanism for Hearing Loss: Modulation of Cochlear Nerve Fibers”
Mar. 14, 2025

The Brain’s Adaptive Mechanism for Hearing Loss: Modulation of Cochlear Nerve Fibers

HHTM
A deeper understanding of how the brain regulates sound perception through inner ear nerve fibers could transform the way hearing loss is diagnosed and managed. In this conversation, Dr. John Oghalai explores groundbreaking research that uncovers the brain’s role in modulating cochlear nerve fibers to adjust sound levels in response to hearing loss. These findings provide new insights into auditory
Featured image for “Giants of Audiology: Interview with Barry Freeman, PhD”
Mar. 10, 2025

Giants of Audiology: Interview with Barry Freeman, PhD

HHTM
Dr. Barry Freeman has had a distinguished career that spans academia, private practice, industry and global audiology education. As a past president of the American Academy of Audiology, Dr. Freeman has been instrumental in shaping the profession, advancing the recognition of audiologists, and promoting access to quality hearing care. Dr. Freeman has been at the forefront of transforming audiology into
Featured image for “Signia Pure Charge&Go BCT IX: Taking a Closer Look”
Mar. 04, 2025

Signia Pure Charge&Go BCT IX: Taking a Closer Look

HHTM
The Signia Pure Charge&Go BCT IX hearing aids bring several advanced upgrades designed to enhance the user experience. Powered by a newly redesigned chip, these hearing aids offer improved sound quality and extended battery life, providing up to 36 hours of use, including five hours of streaming. New features, such as a convenient LED light indicator and a tactile button
Featured image for “InnoCaption Connect: Bridging the Communication Gap for Deaf and Hard-of-Hearing Inmates”
Feb. 25, 2025

InnoCaption Connect: Bridging the Communication Gap for Deaf and Hard-of-Hearing Inmates

HHTM
Access to communication is a fundamental right, yet for many individuals who are Deaf or hard of hearing in the prison system, it remains a significant challenge. In this discussion, Paul Lee, COO of InnoCaption, joins Shari Eberts to discuss InnoCaption Connect, a program designed to bring real-time captioned calls to incarcerated individuals. With an estimated 10% of the prison
Featured image for “Regulation, Innovation, and the Road to Fully Implantable Hearing Devices”
Feb. 17, 2025

Regulation, Innovation, and the Road to Fully Implantable Hearing Devices

HHTM
Hearing technology is evolving, and fully implantable devices are becoming a reality. In this discussion, Brent Lucas, CEO of Envoy Medical, joins Shari Eberts to talk about the company’s fully implantable hearing solutions, including the Esteem active middle ear implant and the Acclaim fully implantable cochlear implant, which is currently in clinical trials. Unlike traditional hearing aids and cochlear implants,
Featured image for “Can Genetic Research Unlock a Cure for Hearing Loss? Exploring the Future of Personalized Treatment with Dr. Christo Bester”
Feb. 11, 2025

Can Genetic Research Unlock a Cure for Hearing Loss? Exploring the Future of Personalized Treatment with Dr. Christo Bester

HHTM
Will genetic therapies revolutionize hearing loss treatment? Dr. Christo Bester, Head of Implant Innovation at Ear Science Institute Australia, discusses the emerging role of gene therapy and personalized medicine in hearing restoration. He highlights the Aussie Earbank initiative, a pioneering effort to collect genetic samples and audiometric data, helping researchers develop targeted treatments. With over 155 genes linked to hearing